Publications by authors named "A P A Kallio"
Background: The burden associated with the treatment of patients with multiple myeloma (MM) is expected to increase due to the aging population. Thus, policymakers and clinicians need a holistic view of the healthcare resource use (HCRU) and costs associated with MM and its treatment for informed decision making. However, nationwide information on HCRU and costs due to MM is scarce in Finland.
View Article and Find Full Text PDFBackground: Primary sclerosing cholangitis is a progressive inflammatory liver disease characterized by biliary and liver fibrosis. Vascular adhesion protein-1 (VAP-1) is important in the inflammatory process driving liver fibrosis. We evaluated the safety and efficacy of VAP-1 blockade with a monoclonal antibody (timolumab, BTT1023) in patients with primary sclerosing cholangitis.
View Article and Find Full Text PDFWe aimed to identify parents' dental anxiety trajectories and the association of the trajectories with the number of parents' and their children's oral healthcare procedures in the FinnBrain Birth Cohort Study. Dental anxiety was measured with the Modified Dental Anxiety Scale at gestational weeks (gw) 14 and 34, as well as 3 and 24 months (mo) after childbirth. Oral healthcare procedures from gw14 to 24 mo were obtained from the national patient data register and categorized as preventive and treatment.
View Article and Find Full Text PDFArticle Synopsis
- Plasmonic photocatalysis traditionally relies on expensive materials like silver (Ag) and gold (Au), which limits its widespread use.
- Researchers developed a new method using affordable materials, specifically HMoO and palladium (Pd), through a solventless mechanochemical synthesis, enhancing photocatalytic activity in the visible spectrum.
- By studying the effects of different light excitation wavelengths on photocatalytic reactions, they found that combining two specific wavelengths led to a 110% improvement in efficiency, demonstrating the potential for creating cost-effective visible-light photocatalysts with readily available materials.
This study aimed to determine the incidence and prevalence of multiple myeloma (MM) in Finland in 2015-2019, to characterize adult patients newly diagnosed with MM, and to follow-up their overall survival (OS) and treatment patterns until the end of 2020. We sourced the data on inpatient and outpatient diagnoses, outpatient medication use, and date of death from comprehensive, nationwide registers. We identified 2037 incident patients with MM in 2015-2019.
View Article and Find Full Text PDF